G1 Therapeutics Inc
F:G1H
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
G1 Therapeutics Inc
F:G1H
|
US |
|
British American Tobacco PLC
LSE:BATS
|
UK |
|
A
|
Alps Alpine Co Ltd
SWB:ALE
|
JP |
|
W
|
Worley Ltd
OTC:WYGPF
|
AU |
|
Moody's Corp
BMV:MCO
|
US |
|
Laboratorio Reig Jofre SA
F:FEQ1
|
ES |
|
P
|
PepsiCo Inc
XBER:PEP
|
US |
|
Y
|
Yamaha Motor Co Ltd
SWB:YMA
|
JP |
|
A
|
Avalonbay Communities Inc
F:WV8
|
US |
|
M
|
Magellan Aerospace Corp
OTC:MALJF
|
CA |
|
A
|
Analog Devices Inc
XHAM:ANL
|
US |
|
B
|
Benitec Biopharma Inc
F:BJ93
|
US |
|
Iridium Communications Inc
NASDAQ:IRDM
|
US |
|
E
|
enCore Energy Corp
XBER:6TU
|
US |
|
S
|
Sanlam Ltd
SWB:LA6A
|
ZA |
|
E
|
Equinix Inc
SWB:EQN2
|
US |
|
L E Lundbergforetagen AB (publ)
F:LU3B
|
SE |
|
JEOL Ltd
OTC:JELLF
|
JP |
|
E
|
Extreme Networks Inc
LSE:0IJW
|
US |
|
N
|
Novartis AG
XBER:NOT
|
CH |
|
C
|
China Resources Land Ltd
F:CHZ
|
HK |
|
ARMOUR Residential REIT Inc
F:2AR
|
US |
|
S
|
Southern Copper Corp
XBER:PCU
|
US |
|
W
|
Wacker Chemie AG
XHAM:WCH
|
DE |
Bankruptcy Probability
G1 Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
G1 Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
G1 Therapeutics Inc
NASDAQ:GTHX
|
376.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
381.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
G1 Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, G1 Therapeutics Inc has total debt of 32.9m USD. This includes both short-term (0 USD) and long-term (32.9m USD) debt.
You can find a full breakdown on its Balance Sheet.
